Outcomes and Duration of Pneumocystis jirovecii Pneumonia Therapy in Infants with Severe Combined Immunodeficiency

This retrospective review of patients with severe combined immunodeficiency and Pneumocystis jirovecii pneumonia (PCP) evaluated the relationship between duration of therapy to treat PCP and overall survival. We found that 80% of patients receiving only 21 days of antibiotics survived to 12 months b...

Full description

Saved in:
Bibliographic Details
Main Authors: Lundgren, Ingrid S., Englund, Janet A., Burroughs, Lauri M., Torgerson, Troy R., Skoda-Smith, Suzanne
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3244569/
https://ncbi.nlm.nih.gov/pubmed/21817949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e31822db772
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items